Epidemiological and Clinical Profile of Amyotrophic Lateral Sclerosis in Amur Region
https://doi.org/10.22448/AMJ.2025.2.7-12
EDN: QQFLVI
Abstract
Objective: To determine the epidemiological and clinical characteristics of amyotrophic lateral sclerosis (ALS) in Amur Region.
Material and methods: Medical records of 54 ALS patients (23 women, 31 men) hospitalized in the neurological department of Amur Regional Clinical Hospital between 2012 and 2022 were retrospectively analyzed. The annual incidence of ALS ranged from 0.5 to 1.04 cases per 100,000 population. The mean age at disease onset was 59.37±1.33 years.
Results: The most common clinical onset was lumbar, followed by bulbar and cervical; diffuse onset was the rarest. In lumbar-onset ALS, males significantly predominated (70%, n=19 vs. 30%, n=8). Conversely, cervical onset was more frequent in women (64%, n=7) than in men (36%, n=4). No significant sexbased differences were observed in other onset types. Across all onset forms, the segmental-nuclear disease variant was most prevalent. The most common initial symptoms were unilateral leg weakness (39% of cases, n=21) and bulbar symptoms (20.4%, n=11). Unilateral arm weakness occurred in 9.2% (n=5), reflecting the lower frequency of cervical onset. Other initial manifestations were noted in 31.4% of patients (n=17).
About the Authors
Yu. A. SirenkoRussian Federation
Yulia A. Sirenko
Blagoveshchensk
V. N. Karnaukh
Russian Federation
Valentina N. Karnaukh
Blagoveshchensk
A. P. Duleba
Russian Federation
Andrey P. Duleba
Blagoveshchensk
P. E. Borodin
Russian Federation
Pavel E. Borodin
Blagoveshchensk
References
1. Levitsky G.N. Amyotrophic lateral sclerosis. Moscow: Practical Medicine, 2010. 568 p. ISBN: 978-5-98811-145-0 (In Russ.)
2. Irwin K.E., Sheth U., Wong P.C., et al. Fluid biomarkers for amyotrophic lateral sclerosis: a review. Molecular Neurodegeneration. 2024; 19 (9): 1–18. DOI: https://doi.org/10.1186/s13024-023-00685-6
3. Bryukhovetskiy A.S. Amyotrophic lateral sclerosis. Moscow: NeuroVita, 2022. 366 p. (In Russ.)
4. Chancellor A.M., Hendry A., Caird F.I., et al. Motor neuron disease: A disease of old age. Scottish Medical Journal. 1993; 38 (6): 178–182. DOI: https://doi.org/10.1177/003693309303800606
5. Cendrowsky W., Werder W., Owsianowski M. Analyse epidemiologique de la sclerose laterale amytotrophique sur le terrioire de la Grand Pologne. Acta Neurologica Scandinavica. 1970; 47: 609–617. DOI: https://doi.org/10.1111/j.1600-0404.1970.tb05817.x
6. Gudmundsson K.R. The prevalence of some neurological disease in Island. Acta Neurologica Scandinavica. 1968; 44 (1): 57–69. DOI: https://doi.org/10.1111/j.1600-0404.1968.tb07443.x
7. Zavalishin I.A. Amyotrophic lateral sclerosis. Moscow: GEOTAR-Media, 2009. 272 p. (In Russ.)
8. Jokelainen M. Amyotrophic Lateral Sclerosis in Finland. II: Clinical characteristics. Acta Neurologica Scandinavica. 1997; 56 (3): 194–204. DOI: https:// doi.org/10.1111/j.1600-0404.1977.tb01425.x
9. Gubbay S.S., Kahana E., Zilber N., et al. Amyotrophic Lateral Sclerosis. A study of its presentation and prognosis. Journal of Neurology. 1985; 232 (5): 295–300. DOI: https://doi.org/10.1007/BF00313868
10. Norris F., Shepherd R., Denys E., et al. Onset, natural history and outcome in idiopathic adult motor neuron disease. Journal of the Neurological Sciences. 1993; 118 (1): 48–55. DOI: https://doi.org/10.1016/0022-510x(93)90245-t
11. Konkova D.Y. Clinical case of erroneous diagnosis of myasthenia gravis in a patient with bulbar form of amyotrophic lateral sclerosis. Modern medicine: current issues. 2014: 1–8. (In Russ.)
Review
For citations:
Sirenko Yu.A., Karnaukh V.N., Duleba A.P., Borodin P.E. Epidemiological and Clinical Profile of Amyotrophic Lateral Sclerosis in Amur Region. Amur Medical Journal. 2025;13(2):7-12. (In Russ.) https://doi.org/10.22448/AMJ.2025.2.7-12. EDN: QQFLVI
JATS XML


